Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14626 - 14650 of 14801 in total
Pentavalent Antimony has been investigated for the treatment of Cutaneous Leishmaniasis.
Investigational
Matched Description: … Pentavalent Antimony has been investigated for the treatment of Cutaneous Leishmaniasis. …
PD-98059 is an inhibitor of MAP-kinase kinase activation.
Investigational
Matched Description: … PD-98059 is an inhibitor of MAP-kinase kinase activation.[A253072] …
SPG601 is being investigated for the treatment of fragile X syndrome.
Investigational
Matched Description: … SPG601 is being investigated for the treatment of fragile X syndrome. …
Pelcitoclax is under investigation in clinical trial NCT04210037 (Study of Combination APG-1252 Plus Paclitaxel in Patients With Relapsed/refractory Small Cell Lung Cancer).
Investigational
Matched Description: … Pelcitoclax is under investigation in clinical trial NCT04210037 (Study of Combination APG-1252 Plus …
VAD-044 is an allosteric AKT inhibitor developed by Vaderis Therapeutics AG. It is being investigated for the treatment of Hereditary Hemorrhagic Telangiectasia.
Investigational
Matched Description: … It is being investigated for the treatment of Hereditary Hemorrhagic Telangiectasia.[L46098] …
AUM-601 is a highly selective pan-TRK(tropomyosin receptor kinase). It is currently being investigated in clinical trials for the treatment of cancer.
Investigational
Matched Description: … It is currently being investigated in clinical trials for the treatment of cancer. …
ISO-1 F-18 is under investigation in clinical trial NCT00968656 (Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1).
Investigational
Matched Description: … ISO-1 F-18 is under investigation in clinical trial NCT00968656 (Assessment of Cellular Proliferation …
Cadaverine is a foul-smelling diamine formed by bacterial decarboxylation of lysine.
Experimental
Matched Description: … Cadaverine is a foul-smelling diamine formed by bacterial decarboxylation of lysine. …
Pridopidine has been used in trials studying the treatment of Huntington's Disease.
Investigational
Matched Description: … Pridopidine has been used in trials studying the treatment of Huntington's Disease. …
JNJ-37822681 has been used in trials studying the treatment of Schizophrenia.
Investigational
Matched Description: … JNJ-37822681 has been used in trials studying the treatment of Schizophrenia. …
LY2874455 has been used in trials studying the treatment of Advanced Cancer.
Investigational
Matched Description: … LY2874455 has been used in trials studying the treatment of Advanced Cancer. …
GSBR-1290 is a small molecule agonist of the GLP-1 receptor.
Investigational
Matched Description: … GSBR-1290 is a small molecule agonist of the GLP-1 receptor. …
PV903 is a self administered vaginally delivered recombinant protein for the treatment of recurrent miscarriage, resulting from an intolerant immune response to the developing foetus.
Investigational
Matched Description: … PV903 is a self administered vaginally delivered recombinant protein for the treatment of recurrent miscarriage …
Amcasertib is under investigation in clinical trial NCT02483247 (A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer).
Investigational
Matched Description: … Amcasertib is under investigation in clinical trial NCT02483247 (A Study of BBI503 in Combination With …
D-chiro-Inositol is under investigation in clinical trial NCT03201601 (Evaluation of the Mixture Myoinositol:D-chiro-inositol 3.6:1 in Women With Polycystic Ovary Syndrome).
Investigational
Matched Description: … D-chiro-Inositol is under investigation in clinical trial NCT03201601 (Evaluation of the Mixture Myoinositol …
Acrizanib is under investigation in clinical trial NCT02355028 (LHA510 Proof-of-concept Study as a Maintenance Therapy for Patients With Wet Age-related Macular Degeneration).
Investigational
Matched Description: … Acrizanib is under investigation in clinical trial NCT02355028 (LHA510 Proof-of-concept Study as a Maintenance …
APG-1387 is under investigation in clinical trial NCT04568265 (A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B).
Investigational
Matched Description: … APG-1387 is under investigation in clinical trial NCT04568265 (A Clinical Study of APG-1387 in Combination …
Dimethandrolone Undecanoate is under investigation in clinical trial NCT03455075 (Study of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men).
Investigational
Matched Description: … Dimethandrolone Undecanoate is under investigation in clinical trial NCT03455075 (Study of Spermatogenesis …
BHV-5000 is an orally bioavailable, low-trapping, potent N-methyl-D-aspartate (NMDA) receptor antagonist. The active metabolite of BHV-5000 is lanicemine.
Investigational
Matched Description: … The active metabolite of BHV-5000 is [lanicemine].[L46446] …
Zilpaterol is a β2 adrenergic agonist sold under the trade name, Zilmax, produced by Intervet, a subsidiary of Merck & Co. Zilpaterol is typically fed to cattle in the last three to six weeks of life with a brief washout period to clear the drug from the tissues before slaughter.
Vet approved
Matched Description: … Zilpaterol is a β2 adrenergic agonist sold under the trade name, Zilmax, produced by Intervet, a subsidiary of ... Zilpaterol is typically fed to cattle in the last three to six weeks of life with a brief washout period …
GDC-0084 is under investigation in clinical trial NCT03696355 (Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas).
Investigational
Matched Description: … GDC-0084 is under investigation in clinical trial NCT03696355 (Study of GDC-0084 in Pediatric Patients …
The (R)-enantiomer of rolipram, it is a phosphodiesterase inhibitor with antidepressant properties.
Experimental
Matched Description: … The (R)-enantiomer of rolipram, it is a phosphodiesterase inhibitor with antidepressant properties. …
Displaying drugs 14626 - 14650 of 14801 in total